David Malkin

Researcher

Related Research

Related News & Events

Press Release|October 24, 2023

Blood test detects tumours early in families with cancer

Researchers funded by The Terry Fox Research Institute have demonstrated that by analyzing patients’ blood samples, they are able to detect cancer ear...

Research Highlight|May 09, 2023

Scientists find Li-Fraumeni syndrome defined by more than one gene; expansion of genetic and epigenetic testing will benefit patients

Scientists at The Hospital for Sick Children in Toronto find Li-Fraumeni syndrome may be defined by more than one gene, highlighting the benefits of e...

Research Highlight|May 06, 2022

Re-defining Li-Fraumeni Syndrome: A catchup with Dr. David Malkin, leader of the Terry Fox New Frontiers Program Project Team studying Li-Fraumeni Syndrome

Over the last four years, the team has made significant findings that better help understand, diagnose, and potentially treat this cancer predispositi...

Research Highlight|October 21, 2021

New study reveals the genes that drive cancer in a subset of patients with medulloblastoma

A new international study led by researchers partly funded by the TFRI has uncovered a number of genes that drive cancer in a subset of patients with ...

TFRI News|October 02, 2019

Terry Fox PROFYLE research shows profiling cancer tumours in real time is giving hope to children and young adults previously out of treatment options

Early results show that an innovative research program honouring Terry Fox’s legacy is providing treatment opportunities to children and young adults ...

TFRI News|June 05, 2018

Three top Canadian research teams receive $13 million to solve key cancer challenges

Three outstanding cancer research teams will receive nearly $13 million to continue their investigations into rare tumours, an inherited disorder (Li-...

Press Release|November 24, 2017

Canadian pediatric researchers, funders join forces, commit $16.4M to give young people across the country a fighting chance against cancer

For the first time in Canadian history, more than 30 pediatric cancer research and funding organizations have joined forces through Terry Fox PROFYLE,...

Research Highlight|September 06, 2017

TP53 polymorphisms and MDM2 SNP309 are not correlated with pre-menopausal cancer risk, study suggests

While significant accolades are given to scientists who discover genetic mutations that are linked to cancer, it is equally important to determine fac...

Research Highlight|January 03, 2017

Personalizing treatment for patients with the most common malignant childhood brain tumour

A TFRI-funded research team studying the most common type of brain tumour in children recently demonstrated the benefits of personalizing treatment ...

All News & Events